0.02Open0.07Pre Close1 Volume66 Open Interest85.00Strike Price2.00Turnover3571.06%IV16.74%PremiumNov 22, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type0.0120Delta0.0063Gamma3641.50Leverage Ratio-52.1259Theta0.0000Rho43.59Eff Leverage0.0000Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet